Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 24;25(23):5496.
doi: 10.3390/molecules25235496.

Alkaloids: Therapeutic Potential against Human Coronaviruses

Affiliations

Alkaloids: Therapeutic Potential against Human Coronaviruses

Burtram C Fielding et al. Molecules. .

Abstract

Alkaloids are a class of natural products known to have wide pharmacological activity and have great potential for the development of new drugs to treat a wide array of pathologies. Some alkaloids have antiviral activity and/or have been used as prototypes in the development of synthetic antiviral drugs. In this study, eleven anti-coronavirus alkaloids were identified from the scientific literature and their potential therapeutic value against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is discussed. In this study, in silico studies showed an affinity of the alkaloids for binding to the receptor-binding domain of the SARS-CoV-2 spike protein, putatively preventing it from binding to the host cell. Lastly, several mechanisms for the known anti-coronavirus activity of alkaloids were discussed, showing that the alkaloids are interesting compounds with potential use as bioactive agents against SARS-CoV-2.

Keywords: COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; antiviral drug; coronaviruses; natural products; virus.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1
Figure 1
Main inhibitory actions of alkaloids against coronaviruses.
Figure 2
Figure 2
Chemical structures of bioactive alkaloids against coronavirus.

References

    1. Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;323:1824–1836. doi: 10.1001/jama.2020.6019. - DOI - PubMed
    1. Fuzimoto A.D., Isidoro C. The antiviral and the coronavirus-host protein pathways inhibiting properties of herbs and natural compounds-Additional weapons in the fight against the COVID-19 pandemic? J. Tradit. Complement. Med. 2020 doi: 10.1016/j.jtcme.2020.05.003. - DOI - PMC - PubMed
    1. Choy K.-T., Wong A.Y.-L., Kaewpreedee P., Sia S.-F., Chen D., Hui K.P.Y., Chu D.K.W., Chan M.C.W., Cheung P.P.-H., Huang X. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir. Res. 2020:104786. doi: 10.1016/j.antiviral.2020.104786. - DOI - PMC - PubMed
    1. Kishimoto S., Sato M., Tsunematsu Y., Watanabe K. Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids. Molecules. 2016;21:1078. doi: 10.3390/molecules21081078. - DOI - PMC - PubMed
    1. Aniszewski T. Alkaloids: Chemistry, Biology, Ecology, and Applications. Elsevier; Amsterdam, The Netherlands: 2015.

MeSH terms

LinkOut - more resources